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ABSTRACT
The GAGA transcription factor of Drosophila melano-
gaster  is ubiquitous and plays multiple roles. Charac-
terization of cDNA clones and detection by domain-
specific antibodies has revealed that the 70–90 kDa
major GAGA species are encoded by two open reading
frames producing GAGA factor proteins of 519 amino
acids (GAGA-519) and 581 amino acids (GAGA-581),
which share a common N-terminal region that is linked
to two different glutamine-rich C-termini. Purified
recombinant GAGA-519 and GAGA-581 proteins can
form homomeric complexes that bind specifically to a
single GAGA sequence in vitro. The two GAGA isoforms
also function similarly in transient transactivation
assays in tissue culture cells and in chromatin
remodeling experiments in vitro . Only GAGA-519 protein
accumulates during the first 6 h of embryogenesis.
Thereafter, both GAGA proteins are present in nearly
equal amounts throughout development; in larval
salivary gland nuclei they colocalize completely to
specific regions along the euchromatic arms of the
polytene chromosomes. Coimmunoprecipitation of
GAGA-519 and GAGA-581 from crude nuclear extracts
and from mixtures of purified recombinant proteins,
indicates direct interactions. We suggest that homo-
meric complexes of GAGA-519 may function during
early embryogenesis; both homomeric and heteromeric
complexes of GAGA-519 and GAGA-581 may function
later.
INTRODUCTION
GAGA factor binds specific GA-rich sequences in both euchromatic
and heterochromatic regions of the Drosophila melanogaster
genome (reviewed in 1,2). GAGA factor is localized to numerous
bands along the euchromatic arms of salivary gland polytene
chromosomes (3; Fig. 8). Several of these bands include
housekeeping or developmentally regulated genes with GAGA
factor binding sites in their promoter regions (4). GAGA factor
is also associated with centromeric heterochromatin of preblasto-
derm embryos and in embryo-derived tissue culture cells (5).
Consistent with these patterns of distribution, mutations in the
gene encoding GAGA factor, Trithorax-like (Trl), affect both the
expression of several developmental loci (6,7) and chromosome
segregation and nuclear division (6). Trl mutations also behave as
dominant enhancers of position effect variegation (PEV; the
clonal inactivation of translocated euchromatic sequences by
adjacent heterochromatin) (7). Thus, GAGA factor has both local
and global roles in chromosome structure and function.
GAGA factor can activate promoters containing GAGA
binding sites in transient cotransfection assays (4,8) and in in vitro
transcription reactions (8,9). This transactivation may result from
an anti-repression activity of GAGA factor in the presence of
general DNA-binding transcriptional repressors, such as histone
H1 (10,11), rather than a ‘true activation’ involving interaction
with RNA polymerase. In vivo, GAGA factor binding at the
Drosophila hsp26 promoter is necessary to establish and maintain
nucleosome-free, DNase I hypersensitive sites at the heat shock
elements (HSEs) (12). Heat shock transcription factor binding to
chromatin of the hsp70 promoter in vivo depends on a promoter
architecture established by GAGA factor, TFIID and RNA
polymerase II (13). GAGA factor may also play a role during
RNA polymerase elongation through chromatin in vivo (14). A
recombinant GAGA factor can bind and cause local rearrangement
of nucleosomes over the GAGA binding sites of the hsp70
promoter, creating DNase I hypersensitive sites at the adjacent
TATA box and HSEs during chromatin assembly in vitro (3).
Thus, GAGA factor may function by organizing and/or remodeling
the nucleosome array.
Purification of GAGA factor by biochemical fractionation and
sequence-specific DNA affinity chromatography yields several
polypeptides detected by SDS–PAGE (4,9,11,15,16). The patterns
of bands are slightly different between preparations from Drosophila
embryos and tissue culture cells. This multiplicity of GAGA
factors could reflect multiple primary protein sequences, or could
indicate post-translational modification. Purified GAGA proteins
can be modified by galactosyl transferase, indicating that they
bear O-linked N-acetylglucosamine monosaccharide residues (17),
which may alter electrophoretic mobility of proteins on SDS–
PAGE. It is not known whether heterogeneity in GAGA factor
would have any consequences for the various nuclear processes
in which GAGA factor may be involved.
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Here we have dissected the multiplicity of GAGA factor by
characterizing several distinct full-length GAGA factor cDNA
clones; immunodetection using antibodies against specific domains
of the GAGA proteins has identified the specific products. Two
major primary isoforms for GAGA factor have been identified,
GAGA-519 and GAGA-581, which share an N-terminal protein–
protein interaction domain and a DNA binding domain, but differ
in their C-termini. Both GAGA factor isoforms exhibit a full
spectrum of biological activity.
MATERIALS AND METHODS
Sequence accession numbers
The nucleotide accession numbers of the cDNA sequences are
U16728 (GAGA-581), U18386 (GAGA-519a) and U68563
(GAGA-519b).
GAGA factor cDNA clones
The first GAGA cDNA clone recovered in the study, GAGA-519c,
was obtained by screening an ovarian cDNA expression library
in λgt11 (gift of Laura Kalfayan) using a 32P-end-labelled
multimer of the 36 bp double-stranded oligonucleotide containing
the Adf-2a binding site, from –215 to –184 of the distal ADH
transcription start site (18). Additional cDNA clones were
identified by hybridization and analyzed by restriction mapping;
representative clones of each class were sequenced.
Anti-GAGA factor antibodies
To generate anti-GAGABTB-ZF-C-ter 519, rats were immunized
with purified maltose binding protein-GAGA-519 [amino acids (aa)
38–519] a fusion protein expressed from pMAL-c2-GAGA-519
(New England Biolabs). Isoform-specific rabbit antisera, anti-
GAGAC-ter 519 (aa 419–519) and anti-GAGAC-ter 581 (aa 381–581)
were obtained by immunization with isoform-specific polypeptides
fused in frame to glutathione-S-transferase (GST), expressed
from pGEX-KT (20). Antibody affinity purification was performed
by first depleting anti-GST antibodies by adsorption of the crude
antiserum to nitrocellulose-bound purified GST. The residual
antibodies were then adsorbed to filters bound with the respective
purified fusion proteins and the specifically bound antibody
eluted with 0.2 M glycine pH 2.8.
Expression and purification of GAGA factors
Recombinant proteins were expressed from pAR-GAGA-519 (4)
and pAR-GAGA-581. Both fusion proteins lack the five N-terminal
aa and substitute 13 aa from T7 gene 10. GAGA factors were
purified from Escherichia coli BL21 pLysS lysates by chromato-
graphy over heparin agarose (21).
Competition gel mobility shift assay
Purified recombinant GAGA factors (250 ng) were incubated on
ice for 20 min with ∼1 ng of 32P-labelled 200 bp DNA fragment
containing the Adf-2b site (from –136 to +64 of the distal ADH
transcription start site), 500 ng of poly (dI-dC), with or without
unlabelled competitor DNA in 20 µl reaction mixtures (25 mM
Tris–HCl pH 7.6, 50 mM KCl, 0.5 mM EDTA, 2.5 mM DTT, 5%
glycerol, 1 mg/ml BSA and 0.05% NP-40). Competitor DNA
fragments were gel-isolated from plasmids containing the
multimerized 6mer of the 32 bp wild-type Adf-2a site (from –215
to –184), or the multimerized 6mer of the 29 bp mutated Adf-2a
site with a 3 bp deletion of nucleotides between –198 and –200
(15). Samples were electrophoresed through 1% agarose gels in
0.5× Tris–borate–EDTA buffer. The agarose gels were dried and
exposed to X-ray film.
Drosophila expression vectors
Expression plasmids were constructed by inserting the GAGA
factor ORFs downstream of the Drosophila metallothionein (Mt)
gene promoter at the SmaI site in the vector pRmHa3 (22). cDNA
inserts containing the intact ORFs for GAGA-519 and
GAGA-581 (2.25 and 3.3 kb, respectively) were removed from
the pNB 40 expression vector (19) by HindIII–NotI double
digests. The ends were filled in using DNA polymerase (Klenow
fragment) and the fragments were cloned in both the sense and the
antisense orientations in pRmHa3.
Transient transfection of Drosophila cell lines
ADH-non-expressing S2 and ADH-expressing 1006-2 cells were
transfected by calcium phosphate coprecipitation (23,24). After
24 h, induction of the GAGA factor expression vector was
performed by adding CuSO4 to a final concentration of 0.7 mM.
At 48 h, cells were harvested; 25% of the cells were lysed in a
nuclear buffer (15). Proteins in the pelleted nuclei were analyzed
by Western blot analysis. The rest of the cells were assayed for
ADH and β-galactosidase activity (23,24).
Chromatin assembly and MNase digestions
Regularly spaced nucleosomal arrays were assembled on the
plasmid pdhspXX3.2 containing the –1.5 to +1.8 kb region of the
Drosophila hsp70 gene using the Drosophila embryo extract
(3,26). A typical reaction contained 300 ng pdhspXX3.2 and 700 ng
RF ΦX174 DNA with or without addition of purified recombinant
GAGA factor and was incubated for 6 h at 26C. MNase
digestions, agarose gel electrophoresis of nucleosomal DNA and
Southern blotting were as described (3).
Developmental Western analysis
Staged wild-type (Canton-S) Drosophila embryos, larvae, pupae,
adult flies and hand-dissected mid-third instar larval fat body and
salivary gland were homogenized directly in SDS–protein gel
sample buffer, the samples boiled and frozen in liquid nitrogen.
Samples were separated by SDS–PAGE, transferred to nitrocellu-
lose and the filters probed with either rat or rabbit affinity-purified
primary antibodies directed against a GAGA factor. Secondary
antibody detection was performed with Amersham’s ECL
(Enhanced Chemiluminescence) kit.
Double immunofluorescence staining
Polytene chromosomes from third instar larval salivary glands
were fixed with 2% formaldehyde and squashed in 45% acetic
acid; the chromosomes were then simultaneously incubated with
affinity-purified rat anti-GAGABTB-ZF-C-ter 519 and affinity-purified
rabbit anti-GAGAC-ter 581 antibodies. The rat antibody was detected
using FITC-conjugated goat anti-rat IgG; the rabbit antibody was
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Immunoprecipitation assays
Purified recombinant GAGA proteins, or their equal mixtures, or
crude KcO nuclear extracts (15) were incubated at 4C for 1 h
with various rabbit sera in 100 µl IP buffer (50 mM Tris–HCl pH
8.0, 0.15 M NaCl and 1% NP-40). Aliquots (100 µl) of a 50%
slurry of protein A–agarose (IPA 300, Repligen) was added and
after incubation at 4C for 1 h with rotation, the beads were
recovered by centrifugation and washed four times with RIPA
(50 mM Tris–HCl pH 8.0, 0.15 M NaCl, 1% NP-40, 0.1% SDS
and 0.1% DOC). The proteins were eluted by boiling in SDS–
protein gel sample buffer and analyzed by Western blot analysis.
RESULTS
Complexity of GAGA factor revealed by cDNA clones 
Several polypeptides are present in preparations of DNA
affinity-purified GAGA factor from Drosophila embryos and
tissue culture cells (4,9,11,15,16). Western blot analyses using
antisera against the polypeptide encoded by the GAGA-519c
cDNA clone (Fig. 1a) also detect several polypeptides, ranging
from ∼70 to ∼160 kDa, in varying abundance (3–6,14; Fig. 2). By
screening a cDNA library we have recovered the same clone and
further identified four different GAGA factor cDNA classes
(Fig. 1a); three of these encode a 519 aa ORF beginning with a
methionine residue and one encodes a 581 aa ORF (Fig. 1b).
Clones GAGA-519a, GAGA-519b and GAGA-581 (but not
GAGA-519c, see legend to Fig. 1a) possess long poly-A tails and
likely represent GAGA factor mRNAs. Comparison of various
GAGA factor cDNA structures indicates that they most likely
arose from alternative splicing of transcripts from the Trl locus.
The sizes of these cDNA clones are in general consistent with the
sizes of the multiple GAGA factor poly-A+ RNAs observed
(from ∼2.4 to 4.4 kb); these RNAs are displayed in complex
patterns during development (4,6). 
The 519 and 581 aa ORFs share the N-terminal amino acids
1–377, but differ in their C-termini (Fig. 1b). The predicted
shared region includes the BTB or POZ domain, a 110 aa block
sharing significant homology (∼50% identity) with the N-terminal
regions of several Drosophila and vertebrate zinc finger proteins,
as well as the poxvirus proteins (2). In vitro studies have shown
that this domain can mediate both homomeric and heteromeric
protein interactions (28,29,30). Both ORFs also share a single
Cys2–His2 zinc finger flanked by basic residues; together, these
elements constitute a high affinity sequence-specific DNA binding
domain (31). The two different C-termini are rich in glutamine,
23% (33 of 142 aa) in GAGA-519 and 42% (85 of 204 aa) in
GAGA-581. The most striking difference between the two ORFs
is the length and number of the polyglutamine stretches (two
stretches of seven and six residues in GAGA-519, three stretches
of 16, 13 and 19 residues in GAGA-581).
Unexpectedly, the additional 1.8 kb cDNA sequence in
GAGA-519b contains a 1 kb long ORF following the termination
codon of the GAGA-519 ORF (Fig. 1a) that encodes several
amino acid repeats and stretches of polyglutamine. The significance
of this new ORF is not yet known; it might code for an additional
C-terminal domain of GAGA factor.
Figure 1. Comparison of the GAGA factor cDNA clones. (a) Four different
cDNA clones have been completely sequenced and their relationship is
indicated in blocks of different patterns. BTB is a conserved 110 aa block (see
text) ZF is a single Cys2-His2 zinc finger flanked by basic residues. Clone
GAGA-581 has a 581 aa ORF. Clones GAGA-519a, GAGA-519b and
GAGA-519c have a 519 aa ORF. Clone GAGA-519c does not have an
authentic poly-A tail; the A-rich stretch at the 3′ end is present in clones
GAGA-519a and GAGA-519b (black box), indicating that the GAGA-519c
clone was probably the result of oligo-dT priming during synthesis of the cDNA
library. Clone GAGA-581 is likely to have been generated by alternative
splicing of the transcript that gave rise to clone GAGA-519a (removing the
GAGA-519C-ter domain coding sequence, as shown by an arrow) 2.3 kb of
clone GAGA-519b is identical to GAGA-519a with an additional 1.8 kb DNA
containing a 322 aa ORF (New ORF). (b) GAGA-519 and GAGA-581 ORFs
share the BTB and the zinc finger domains (in bold), but they differ in their
glutamine-rich C-termini (italicized for GAGA-519) The high affinity DNA
binding domain (31) is underlined.
Complexity of GAGA factor revealed by domain-specific
immunodetection
To verify the existence of multiple GAGA factor C-terminal
domains and to dissect the relationship among GAGA factors, we
generated antisera against specific epitopes in the C-terminal
domains of GAGA-519 (aa 419–519) and GAGA-581 (aa 381–581)
using recombinant fusion proteins as immunogens. Figure 2
shows Western blot analysis of a nuclear extract from Drosophila
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Figure 2. Western blot analysis using domain-specific antibodies. Each lane
(1–8) contained a nuclear extract (40 µg) from KcO cells that was fractionated
on a 15 cm 7.5% SDS–PAGE gel, transferred to nitrocellulose, the filter cut
(through lanes 3, 5 and 7) into four sections (A–D) and each section reacted with
various affinity-purified rat (A) and rabbit (B and C) primary antibodies as
indicated. Use of a control goat anti-rat secondary antibody alone is shown (D);
goat anti-rabbit secondary antibody yielded identical results to D (not shown)
gel and probed separately with three different affinity-purified
polyclonal primary antibodies. At least 10 cross-reacting poly-
peptides were detected with a primary antibody against a near
full-length GAGA-519 protein (αGAGABTB-ZF-C-ter 519) (Fig. 2A).
They ranged from ∼70 to 160 kDa in size and were present in
varying abundance. Subsets of these polypeptides could be
identified using antibodies specific to the individual C-terminal
domains. Anti-GAGAC-ter 519 antibody (Fig. 2B) detected the
major polypeptides of 70 and 75 kDa, whereas the major 80, 85
and 90 kDa polypeptides were seen with anti-GAGAC-ter 581
antibody (Fig. 2C). We conclude that these polypeptides are the
translation products of GAGA-519 and GAGA-581 mRNAs,
respectively (Figs 4 and 5). Clearly each polypeptide has been
modified post-translationally. There is a near-equal mixture of the
major 70 and 75 kDa GAGA-519 and the 80 and 90 kDa
GAGA-581 forms (Figs 2A, 7a and b: detection by the common
antibody, αGAGABTB-ZF-C-ter 519). A few of the less abundant
105–160 kDa GAGA cross-reacting polypeptides were detected
by all three affinity-purified antibodies (A, B and C); this might
indicate the existence of additional large GAGA factors that could
result from alternative splicing of Trl transcripts in tissue culture
cells. However, no corresponding cDNA clones have been
recovered.
GAGA-519 and GAGA-581 factors form multiple
nucleoprotein complexes on a single GAGA sequence 
The availability of full-length recombinant GAGA factor cDNA
clones has allowed us to compare DNA binding activities and
Figure 3. GAGA-519 and GAGA-581 factors bind a single GAGA sequence
forming multiple-related nucleoprotein complexes. Purified recombinant
GAGA factor (250 ng) was incubated with a 32P-labelled DNA fragment (from
–136 to +64) from the Adh distal promoter that contains the Adf-2b site with
the 10 bp Adf-2 motif, 5′-TCTCAGTGCA-3′. Unlabelled competitor DNAs
were either the multimerized wildtype Adf-2a site, from –215 to –184, with the
identical 10 bp Adf-2 motif but different flanking sequences, or the
multimerized mutated Adf-2a site with 3 bp deleted from the 10 bp Adf-2 motif.
Nucleoprotein complexes were fractionated on a 1% agarose gel. 
functions of the major GAGA factor isoforms. GAGA factor
binding sites typically contain multiple repeats of GAGA sequence
of various lengths, clustered in the promoter regions within a few
hundred base pairs upstream of the transcription start sites (2). We
recovered the GAGA-519c cDNA clone (Fig. 1a) in binding site
screening experiments using the atypical 10 bp Adf-2 motif from
the Drosophila Adh distal promoter, 5′-TCTCAGTGCA-3′, with
only a single GAGA sequence. Using a competitive gel mobility
shift assay, we have shown that recombinant GAGA proteins can
indeed interact with either Adf-2a (located at –202) or Adf-2b
(located at +8) sites (Fig. 3). Unexpectedly, purified recombinant
GAGA-519 and GAGA-581 factors, each typically one major
single polypeptide detected by SDS–PAGE (Fig. 9a and b),
produced multiple nucleoprotein complexes when bound to a
32P-labelled DNA probe containing the Adf-2b site (Fig. 3). From
each GAGA factor isoform, at least four major nucleoprotein
complexes formed, generating a discrete, regularly spaced ladder
on an agarose gel; their relative mobilities are consistent with
binding of additional GAGA factor molecules. GAGA factor
binding was competed away by the 32 bp DNA sequence
containing the wildtype Adf-2a site; this competition was ∼5-fold
more efficient than that by a 29 bp mutated Adf-2a site, with part
of the single GAGA sequence deleted (Adf-2a∆3). These results
indicate specific and similar binding of either GAGA factor to the
single GAGA sequence in the 10 bp Adf-2 motif, consistent with
the presence of an identical DNA binding domain in both protein
isoforms. Interestingly, multiple, clearly related GAGA factor–DNA
complexes, were detected concomitantly on the Adf-2b site (at
several GAGA protein concentrations, not shown) and all
complexes could be competed similarly (Fig. 3), which suggests
that purified recombinant GAGA-519 and GAGA-581 may exist
as several alternative homomeric complexes, each of which has
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Figure 4. Activation of the Adh distal promoter by GAGA-519. pMt-GAGA-519, in sense and antisense orientations, was transiently transfected into S2
ADH-non-expressing (ADH–) and 1006-2 ADH-expressing (ADH+) cell lines. (a) The metal-inducible expression vector was transfected, along with pDistalAdh,
which contains the wildtype Adh gene (with 660 bp of upstream distal promoter elements and distal enhancer) as a reporter (24), pPacLacZ (containing the Drosophila
constitutive act5C exon 1-proximal promoter fused in frame to LacZ; 25) and pBSKS+. The ADH activity relative to β-galactosidase activity (averages of six
experiments) was measured and is presented as fold increase over the activity seen in the presence of 0.05 µg f the pMt-GAGA-519 expression vector in
ADH-expressing cells. The activity of pDistalAdh is ∼10-fold higher in ADH+ than in ADH– cells (23,32) Error bars indicate ± one standard deviation. (b) Western
blot analysis of nuclear proteins from cells transfected with pMt-GAGA-519 (sense) and probed with affinity-purified rat anti-GAGABTB-ZF-C-ter 519 antibody.
Transfected whole cell lysates were also probed with mouse monoclonal anti-β galactosidase antibody (bottom panel) (c) Western blot analysis of ADH– cells
transfected with pMt-GAGA-519 sense or pMt-GAGA-519 antisense.
Figure 5. Activation of the Adh distal promoter by GAGA-581. (a) pMt-GAGA-581 was transfected, as was done with pMt-GAGA-519 (Fig. 4 legend). (b) Western
blot analysis of nuclear proteins from cells transfected with pMt-GAGA-581 and probed with affinity-purified anti-GAGABTB-ZF-C-ter 519 antibody.
Either GAGA-519 or GAGA-581 activates expression from
the Drosophila Adh distal promoter
We compared the capability of GAGA isoforms to trans-activate
the Drosophila Adh distal promoter by overexpressing them in
tissue culture cells together with an Adh reporter gene, pDistalAdh,
which contains an intact Adh gene in its natural context (24).
Cotransfection experiments were performed in two different cell
lines, ADH-non-expressing cells (ADH–) and ADH-expressing
cells (ADH+) that possess different combinations of trans-acting
factors necessary for Adh distal promoter transcription (15,23,32).
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Figure 6. GAGA-519 and GAGA-581 both mediate specific chromatin
rearrangement at the hsp70 promoter in vitro. Chromatin reconstituted on the
hsp70-plasmid, without or with addition (0.5 and 1 µg) of recombinant
GAGA-519 (top) and GAGA-581 (bottom), was digested with MNase and the
digestion patterns analyzed on agarose gels. Ethidium bromide (EtBr) stains of
MNase digestion patterns are shown on the left; DNA blots were hybridized
sequentially with two oligonucleotide probes: –340 to –311 in the hsp70
promoter, which contains no GAGA binding site and –132 to –113, which
contains several GAGA binding sites (3).
led to gradual increases in the 70/75 kDa GAGA-519 protein
above the endogenous levels in nuclei of both ADH– and ADH+
cells (Fig. 4b and c). Similar levels of overexpressed GAGA-519
proteins were seen in both cell types. In parallel, there were also
gradual increases in ADH expression in a GAGA-519 dosage-
dependent manner; however, the increase was more pronounced
in ADH– cells, ∼2-fold compared to 1.5-fold in ADH+ cells
(Fig. 4a). Trans-activation was due to overexpressed GAGA-519;
pMt-519 expression vector in the antisense orientation did not
produce any 70/75 kDa GAGA-519 above the endogenous level
(Fig. 4c) and did not systematically alter ADH expression from
pDistal Adh (Fig. 4a). In both cell types, overexpression of
GAGA-519 did not affect a second Drosophila promoter, the
act5C exon 1-proximal promoter, which drove the expression of
a transfected LacZ gene (Fig. 4b). This is consistent with previous
findings that transcription from the act5C exon1-proximal
promoter is not dependent on GAGA binding sites (33).
Overexpression of the 80/90 kDa GAGA-581 (Fig. 5b) also
stimulated ADH activity in a dosage-dependent manner, by
2-fold in ADH– cells and by ∼1.5-fold in ADH+ cells (Fig. 5a).
The relatively low level of stimulation suggests that GAGA factor
is not limiting in these cells. In both experiments, transcripts from
the single cDNA clone resulted in the synthesis of multiple
isomers, consistent with the results of Figure 2; this result
supports the inference that these sub-groups of isoforms are the
consequence of post-translational modification. 
GAGA-581, like GAGA-519, can direct rearrangement
of nucleosomes during chromatin assembly in vitro
GAGA factor may function by influencing chromatin structure
(reviewed in 1,2). A recombinant 70 kDa GAGA-519 protein has
Figure 7. Western blot analysis of GAGA factors during development and in
differentiated larval tissues. (a) Equal amounts of protein extracts from staged
animals and 20 µg KcO nuclear extract were fractionated and analyzed using
affinity-purified primary antibodies as indicated. E, embryos (0–3, 3–6, 6–9,
9–12, 12–15, 15–18, 18–21 and 21–24 h); L, larvae (first, second, third and late
third instar); P, pupae (24 h apart); A, adults. (b) Protein extracts from larval fat
body (F, from ∼3 larvae/lane), from salivary gland (S, from ∼3 larvae/lane), and
from a nuclear extract (Kc, 20 µg) were analyzed using affinity-purified
primary antibodies as indicated.
been shown to direct rearrangement of nucleosomes within the
regulatory regions of hsp70 and hsp26 during physiological
chromatin assembly in vitro (3,34). We have confirmed and
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assembly extract from Drosophila embryos to reconstitute
chromatin on an hsp70 plasmid (3). Micrococcal nuclease
digestion patterns indicate the assembly of regularly spaced
nucleosomes on the 6 kb plasmid as a whole with or without
addition of either recombinant GAGA protein (Fig. 6). Nucleosome
rearrangement was observed specifically and locally over the
GAGA binding sites of the hsp70 promoter only when recombinant
GAGA proteins (either isoform) were present. This is indicated
by the disarray of the oligonucleosomal DNA ladder and by the
decrease of mononucleosomal DNA when the Southern blots
were probed with an oligonucleotide containing the GAGA
binding sites. These experiments indicate that recombinant
GAGA-519 and GAGA-581 can function similarly to modulate
chromatin structure in vitro.
Distribution of GAGA factor isoforms during Drosophila
development and differentiation
We have examined GAGA factor isoforms at various developmental
stages and in certain differentiated larval tissues by Western blot
analyses using the domain-specific antibodies described above.
GAGA factors are present at all stages (Fig. 7a); however,
combinations of specific isoforms differ significantly through
development. During early embryogenesis the 70/75 kDa
GAGA-519 proteins are the predominant species. At the start of
organogenesis in 6 h embryos, the 80/90 kDa GAGA-581
proteins begin to accumulate. They become as abundant as the
70/75 kDa forms by 12 h of embryogenesis and throughout
development; this pattern is similar to that seen for tissue culture
cell nuclei (Fig. 7a). Variations are observed in differentiated
larval tissues (Fig. 7b). This may indicate tissue-specific regulation
of post-translational modification.
In larval salivary gland cells, GAGA factors have been
localized along polytene chromosomes to a large number of sites
within the euchromatic part of the genome; no staining is
observed in the heterochromatic chromocenter (3; reviewed in 2).
These earlier experiments detected all GAGA species. To
distinguish the locations of the 70/75 kDa GAGA-519 and the
80/90 kDa GAGA-581 isoforms, we performed indirect immuno-
fluorescent costaining of polytene chromosomes with affinity-
purified rat anti-GAGABTB-ZF-C-ter 519 antibody, which detects
all GAGA species (Fig. 8a) and rabbit anti-GAGAC-ter 581
antibody, which detects only the GAGA-581 species (Fig. 8b).
The merged micrograph (Fig. 8c) reveals, within the limits of
detection, a complete overlap of the specific staining patterns;
there is no difference in the relative intensity of various bands and
of no staining at the chromocenter. Identical observations were
made when affinity-purified rat anti-GAGABTB-ZF-C-ter 519 and
rabbit anti-GAGAC-ter 519 antibodies were used (not shown).
Strikingly, neither GAGA-581 or GAGA-519 signals were seen
alone (Fig. 8c). These observations indicate that the major
GAGA-581 and GAGA-519 proteins, which coexist in near-
equal amounts in salivary gland nuclei as shown by Western blot
analysis (Fig. 7b), colocalize completely to specific chromosomal
regions. Our observations raise the significant possibility that in
differentiated tissues such as salivary gland, GAGA-519 and
GAGA-581 might bind chromatin as heteromeric protein
complexes. However, the absence of 80/90 kDa GAGA-581
during the first 6 h of embryogenesis (Fig. 7a) indicates that
GAGA-519 can also function without GAGA-581 proteins.
Figure 8. Colocalization of GAGA-519 and GAGA-581 along polytene
chromosomes. (a), (b) (c) Fluorescent micrographs of a single set of polytene
chromosomes costained with affinity-purified anti-GAGABTB-ZF-C-ter 519
(green) and anti-GAGAC-ter 581 (red) antibodies. (c) Double exposure (merged)
showing regions of overlap (yellow). Note the absence of chromocenter staining
(upper right).
Direct heteromeric protein interactions between GAGA
factor isoforms
To investigate whether GAGA-519 and GAGA-581 proteins
physically interact, we performed immunoprecipitation assays
(Fig. 9). Under conditions where pre-immunization rabbit sera
failed to precipitate purified recombinant GAGA factors, both
soform-specific antibodies precipitated only their antigens and
specifically detected these antigens in western blot analysis (Fig. 9a).
When recombinant GAGA factors were mixed together prior to
immunoprecipitation (Fig. 9b), anti-GAGAC-ter 519 antibody
specifically precipitated both GAGA-519 (lanes 2 and 6) and
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Figure 9. Heteromeric interactions of GAGA factor isoforms. (a) Specificity of anti-GAGA antibodies. Purified recombinant GAGA-519 or GAGA-581 (250 ng each)
was incubated with the indicated rabbit sera (αGAGAC-ter 519, αGAGAC-ter 581 and pre-immunized rabbit serum; see Materials and Methods) Proteins in each
immunoprecipitate were divided into two halves, fractionated on an 8% SDS–PAGE gel and each half was analyzed by Western blotting with affinity-purified primary
antibodies as indicated. Goat anti-rabbit IgG was used as the secondary antibody in the chemiluminescence detection; it recognized p ipitating rabbit antibodies
bound to protein A beads, as expected. (b) Heteromeric interactions between GAGA-519 and GAGA-581. Mixtures of purified recombinant GAGA-519 and
GAGA-581 (1 µg each) were pre-incubated in a solution containing either 0.15 M NaCl (lanes 1–4, 9–12 and 17), or 0.5 M NaCl (lanes 5–8 and 13–16) for 1 h at
4C. The immunoprecipitation and Western blot assays were then performed on equal aliquots of these samples as described above. Lan s 1, 5, 9 and 13 contained
125 ng each of GAGA-519 and GAGA-581 loaded directly onto the gel. Lane 17 shows the reprobing of proteins in lane 1 with rat anti-GAGABTB-ZF-C-ter 519 antibody.
(c) Heteromeric complexes of GAGA-519 and GAGA-581 in tissue culture cell nuclear extract. 1.5 mg of crude KcO nuclear extract was pre-incubated with protein
A beads; equal aliquots were then immunoprecipitated (with 2.5 µl of the indicated rabbit sera, lanes 1–3) and analyzed by Western blotting with rat
anti-GAGABTB-ZF-C-ter 519 antibody. Lane 4, protein A beads after pre-incubation with the crude nuclear extract. Lane 5, 20 µg of KcO nuclear extract.
antibody specifically precipitated GAGA-519 (lanes 3 and 7) as
well as GAGA-581 (lanes 11 and 15). GAGA factor associations
appear unaffected by salt concentrations [range from 0.5 M NaCl
(Fig. 9b) to 0.05 M NaCl (result not shown)]. In addition,
GAGA-519 and GAGA-581 proteins, including their in vivo
modified subtypes, could be specifically coimmunoprecipitated
from crude tissue culture cell nuclear extracts (Fig. 9c). Note that
the levels of GAGA isoform association seen in Figure 9c, lanes 2
and 3 may be an underestimate, as the specific precipitating
polyclonal antibodies may interfere with GAGA protein inter-
actions. Together, our observations in Figures 8 and 9 indicate
strongly that heteromeric complexes of GAGA-519 and
GAGA-581 exist in vivo.
DISCUSSION
GAGA factor is a remarkable protein. It binds with high affinity
to a discrete set of specific DNA sequences; it can direct specific
modulation of the nucleosome array and it has been shown by
genetic analysis to have an effect on higher order chromatin
tructure (reviewed in 1,2). Multiple isoforms of GAGA factor
have been recognized for some time, but the source of this
variation had not been identified. We have presented a set of
experiments indicating that the GAGA factors consist of several
related nuclear proteins, all encoded by the Trithorax-like gene.
The GAGA proteins share a common N-terminal region that is
linked to two different C-terminal domains. Alternative splicing
of Trl transcripts is the most likely mechanism to yield such
polypeptides both sharing and differing in primary sequences.
Both primary GAGA species are apparently modified post-
translationally to generate subsets with altered electrophoretic
mobility. Both splicing of Trl RNA and GAGA protein modification
are regulated processes, since combinations and amounts of
various GAGA species differ during development and in specific
cell types.
We have identified two major forms of GAGA factor, the 70/75
kDa GAGA-519 and the 80-90 kDa GAGA-581; there may be
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GAGA-581 are relatively abundant and likely to have significant
functional roles. Only GAGA-519 proteins accumulate during the
first 6 h of embryogenesis, thereafter both GAGA-519 and
GAGA-581 are present in near-equal amounts throughout devel-
opment (Fig. 7a and b). Thus, GAGA-519 proteins are likely to be
the GAGA factor involved in transcriptional regulation and nuclear
division in early embryos (6). However, within the limits of
detection, GAGA-519 and GAGA-581 completely colocalize to
specific regions along euchromatic arms of salivary gland polytene
chromosomes (Fig. 8c). This observation, coupled with tests
indicating similar functional capabilities, suggests that GAGA-519
and GAGA-581 both function in later developmental stages; they
may function together as heteromeric protein complexes (Fig. 9b
and c) when they coexist in near equal amounts (Figs 2, 7a and b)
in the same nucleus (Fig. 8).
GAGA proteins can form both homo- and heteromeric com-
plexes. We detected similar multiple-related large GAGA factor–
DNA complexes when either purified recombinant GAGA- 519 or
GAGA-581, each a single polypeptide, bound specifically to a
single GAGA sequence within the Adf-2 motif (Fig. 3) Our results
suggest stable homomeric interactions of GAGA proteins. Further
experiments (Figs 8 and 9) indicate that GAGA-519 and
GAGA-581 form heteromeric complexes in vivo and in vitro. Such
stable protein homo- and heteromultimerization might be mediated
by either the BTB domain (28–30) and/or by the glutamine repeats
(35–38). Whatever the mechanisms responsible, the complete
colocalization of GAGA-519 and GAGA-581 suggests that the
heteromeric GAGA complexes may be the preferred stable
structures when both isoforms coexist in vivo.
Two different assays have shown that GAGA-519 and
GAGA-581 can function similarly. In transient cotransfection
assays in tissue culture cells, overproduction of either GAGA-519
or GAGA-581 stimulated expression from theAdh distal promoter
(Figs 4 and 5). Given that the endogenous factor was present in
both forms (Fig. 2), the active species could be a homomer or
heteromer. In chromatin remodeling experiments where purified
recombinant GAGA proteins were used (Fig. 6), the active
structures were probably homomeric complexes. These two
functional assays confirmed that GAGA-519 and GAGA-581 have
similar sequence-specific DNA binding activities and interact
similarly with other trans-acting factors and the general transcrip-
tional machinery in vivo, as well as with nucleosomes and
nucleosome remodeling factors in vitro.
In summary, it appears that complexity of GAGA factors exists
at several levels: multiple primary amino acid sequences, varying
levels of post-translational modification of the same GAGA
polypeptide and potentially distinct homo- and heteromeric
complexes. It appears possible that the multimerization of GAGA
factor into higher-order complexes may play a role in the
organization of higher-order chromatin structure (7), for example
by generating stable chromatin loops between distant regulatory
regions that contain GAGA factor binding sites. In addition,
GAGA factor interactions may be involved in the recruitment of
additional GAGA factor to active transcription units and in the
spreading of GAGA factor to open the chromatin structure during
RNA polymerase elongation i vivo (14). Such protein–protein
interactions may well be critical for the mechanism(s) by which
this specific DNA-binding protein affects higher order chromatin
structure.
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